Publication | Open Access
Multiplex Detection of Clinically Relevant Mutations in Liquid Biopsies of Cancer Patients Using a Hybridization-Based Platform
17
Citations
20
References
2020
Year
The nCounter platform requires less DNA than NGS and can be employed for routine mutation testing in liquid biopsies of patients with cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1